Stable oncogenic silencing in vivo by programmable and targeted de novo DNA methylation in breast cancer.
Ontology highlight
ABSTRACT: With the recent comprehensive mapping of cancer genomes, there is now a need for functional approaches to edit the aberrant epigenetic state of key cancer drivers to reprogram the epi-pathology of the disease. In this study we utilized a programmable DNA-binding methyltransferase to induce targeted incorporation of DNA methylation (DNAme) in the SOX2 oncogene in breast cancer through a six zinc finger (ZF) protein linked to DNA methyltransferase 3A (ZF-DNMT3A). We demonstrated long-lasting oncogenic repression, which was maintained even after suppression of ZF-DNMT3A expression in tumor cells. The de novo DNAme was faithfully propagated and maintained through cell generations even after the suppression of the expression of the chimeric methyltransferase in the tumor cells. Xenograft studie
SUBMITTER: Stolzenburg S
PROVIDER: S-EPMC4633433 | biostudies-literature | 2015 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA